UBS AM’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.4M | Buy |
500,697
+200,501
| +67% | +$7.38M | ﹤0.01% | 1084 |
|
|
2025
Q1 | $10.6M | Buy |
300,196
+37,345
| +14% | +$1.32M | ﹤0.01% | 1197 |
|
|
2024
Q4 | $11.5M | Buy |
262,851
+46,825
| +22% | +$2.05M | ﹤0.01% | 1186 |
|
|
2024
Q3 | $9.8M | Sell |
216,026
-25,421
| -11% | -$1.15M | ﹤0.01% | 1233 |
|
|
2024
Q2 | $9.37M | Buy |
241,447
+108,273
| +81% | +$4.2M | ﹤0.01% | 1164 |
|
|
2024
Q1 | $4.29M | Hold |
133,174
| – | – | ﹤0.01% | 1324 |
|
|
2023
Q4 | $3.82M | Buy |
133,174
+28,936
| +28% | +$830K | ﹤0.01% | 1382 |
|
|
2023
Q3 | $2.89M | Buy |
104,238
+13,913
| +15% | +$385K | ﹤0.01% | 1447 |
|
|
2023
Q2 | $1.96M | Hold |
90,325
| – | – | ﹤0.01% | 1657 |
|
|
2023
Q1 | $1.96M | Buy |
90,325
+27,424
| +44% | +$594K | ﹤0.01% | 1657 |
|
|
2022
Q4 | $1.5M | Buy |
62,901
+18,910
| +43% | +$450K | ﹤0.01% | 1664 |
|
|
2022
Q3 | $868K | Buy |
43,991
+461
| +1% | +$9.09K | ﹤0.01% | 2049 |
|
|
2022
Q2 | $848K | Sell |
43,530
-14,008
| -24% | -$273K | ﹤0.01% | 2057 |
|
|
2022
Q1 | $1.47M | Buy |
57,538
+16,724
| +41% | +$427K | ﹤0.01% | 1951 |
|
|
2021
Q4 | $1.03M | Buy |
40,814
+1,982
| +5% | +$49.9K | ﹤0.01% | 2199 |
|
|
2021
Q3 | $1.07M | Buy |
38,832
+372
| +1% | +$10.2K | ﹤0.01% | 2135 |
|
|
2021
Q2 | $1.22M | Buy |
38,460
+16,160
| +72% | +$513K | ﹤0.01% | 2106 |
|
|
2021
Q1 | $1.02M | Sell |
22,300
-2,529
| -10% | -$116K | ﹤0.01% | 2082 |
|
|
2020
Q4 | $983K | Buy |
24,829
+17,729
| +250% | +$702K | ﹤0.01% | 2005 |
|
|
2020
Q3 | $247K | Buy |
+7,100
| New | +$247K | ﹤0.01% | 2348 |
|